Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 414

1.

Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.

Liu M, Jiang L, Fu X, Wang W, Ma J, Tian T, Nan K, Liang X.

Cancer Sci. 2018 Oct;109(10):3055-3067. doi: 10.1111/cas.13746.

2.

Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy.

Hu MT, Wang JH, Yu Y, Liu C, Li B, Cheng QB, Jiang XQ.

Int J Oncol. 2018 Sep;53(3):1215-1226. doi: 10.3892/ijo.2018.4466. Epub 2018 Jul 2.

PMID:
30015925
3.

Liver kinase B1 suppresses growth of lung cancer cells through sonic hedgehog signaling pathway.

Song K, Zheng G, Zhao Y.

Cell Biol Int. 2018 Aug;42(8):994-1005. doi: 10.1002/cbin.10965. Epub 2018 May 29.

PMID:
29573522
4.

[Identification of a novel STK11 gene mutation in a family affected with hereditary Peutz-Jeghers syndrome].

Xu C, Ma Y, Cao F, Zhao H, Wang Y, Xiao Z, Tang J, Yan F, Sun P, Zhang N, Tao J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Feb 10;35(1):89-91. doi: 10.3760/cma.j.issn.1003-9406.2018.01.020. Chinese.

PMID:
29419869
5.

A novel mutation (c.855delG) in STK11 gene is associated with Peutz-Jeghers syndrome in a Chinese family.

Zhao ZY, Jiang YL, Li BR, Yu ED, Ning SB.

Dig Liver Dis. 2018 Mar;50(3):312-314. doi: 10.1016/j.dld.2017.12.007. Epub 2017 Dec 19. No abstract available.

PMID:
29301733
6.

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value.

Facchinetti F, Bluthgen MV, Tergemina-Clain G, Faivre L, Pignon JP, Planchard D, Remon J, Soria JC, Lacroix L, Besse B.

Lung Cancer. 2017 Oct;112:62-68. doi: 10.1016/j.lungcan.2017.08.002. Epub 2017 Aug 7.

PMID:
29191602
7.
8.

Liver kinase B1 restoration promotes exosome secretion and motility of lung cancer cells.

Zhang C, Xiao X, Chen M, Aldharee H, Chen Y, Long W.

Oncol Rep. 2018 Jan;39(1):376-382. doi: 10.3892/or.2017.6085. Epub 2017 Nov 9.

9.

A 23-Nucleotide Deletion in STK11 Gene Causes Peutz-Jeghers Syndrome and Malignancy in a Chinese Patient Without a Positive Family History.

Zhao ZY, Jiang YL, Li BR, Yang F, Li J, Jin XW, Ning SB, Sun SH.

Dig Dis Sci. 2017 Nov;62(11):3014-3020. doi: 10.1007/s10620-017-4741-5. Epub 2017 Oct 6.

PMID:
28986664
10.

Phe354Leu Polymorphism of LKB1 Is a Potential Prognostic Factor for Cytogenetically Normal Acute Myeloid Leukemia.

Yang MY, Hsiao HH, Liu YC, Hsu CM, Lin SF, Lin PM.

In Vivo. 2017 Sep-Oct;31(5):841-847.

11.

Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis.

Liu Z, Zhu H, Dai X, Wang C, Ding Y, Song P, Zou MH.

Circ Res. 2017 Oct 13;121(9):1047-1057. doi: 10.1161/CIRCRESAHA.117.311546. Epub 2017 Aug 21.

12.

LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.

Trapp EK, Majunke L, Zill B, Sommer H, Andergassen U, Koch J, Harbeck N, Mahner S, Friedl TWP, Janni W, Rack B, Alunni-Fabbroni M.

Mol Oncol. 2017 Nov;11(11):1508-1526. doi: 10.1002/1878-0261.12111. Epub 2017 Sep 30.

13.

LKB1 promotes radioresistance in esophageal cancer cells exposed to radiation, by suppression of apoptosis and activation of autophagy via the AMPK pathway.

He Q, Li J, Dong F, Cai C, Zou X.

Mol Med Rep. 2017 Aug;16(2):2205-2210. doi: 10.3892/mmr.2017.6852. Epub 2017 Jun 23.

PMID:
28656285
14.

Live kinase B1 maintains CD34+CD38- AML cell proliferation and self-renewal.

Wang H, Wang X, Xin N, Qi L, Liao A, Yang W, Liu Z, Zhao C.

Mol Cell Biochem. 2017 Oct;434(1-2):25-32. doi: 10.1007/s11010-017-3032-y. Epub 2017 Apr 10.

PMID:
28397012
15.

Association between STK11 Gene Polymorphisms and Coronary Artery Disease in Type 2 Diabetes in Han Population in China.

Ma X, Bai G, Lu D, Huang L, Zhang J, Deng R, Ding S, Gu N, Guo X.

J Diabetes Res. 2017;2017:6297087. doi: 10.1155/2017/6297087. Epub 2017 Feb 28.

16.

A lesson from a reported pathogenic variant in Peutz-Jeghers syndrome: a case report.

Tan H, Wei X, Yang P, Huang Y, Li H, Liang D, Wu L.

Fam Cancer. 2017 Jul;16(3):417-422. doi: 10.1007/s10689-016-9963-8.

PMID:
28185117
17.

LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab.

Bonanno L, De Paoli A, Zulato E, Esposito G, Calabrese F, Favaretto A, Santo A, Conte AD, Chilosi M, Oniga F, Sozzi G, Moro M, Ciccarese F, Nardo G, Bertorelle R, Candiotto C, De Salvo GL, Amadori A, Conte P, Indraccolo S.

Clin Cancer Res. 2017 Jul 1;23(13):3316-3324. doi: 10.1158/1078-0432.CCR-16-2410. Epub 2017 Jan 24.

18.

LKB1 promotes metabolic flexibility in response to energy stress.

Parker SJ, Svensson RU, Divakaruni AS, Lefebvre AE, Murphy AN, Shaw RJ, Metallo CM.

Metab Eng. 2017 Sep;43(Pt B):208-217. doi: 10.1016/j.ymben.2016.12.010. Epub 2016 Dec 26.

19.

[Overexpression of liver kinase B1 inhibits the proliferation of lung cancer cells].

Li Y, Zhang L, Wang P.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Jan;33(1):39-43. Chinese.

PMID:
28031112
20.

LKB1 as a Tumor Suppressor in Uterine Cancer: Mouse Models and Translational Studies.

Peña CG, Castrillón DH.

Adv Exp Med Biol. 2017;943:211-241. Review.

PMID:
27910069

Supplemental Content

Support Center